Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China flag China · Delayed Price · Currency is CNY
5.96
+0.03 (0.51%)
Mar 30, 2026, 3:04 PM CST
Market Cap4.84B +3.7%
Revenue (ttm)834.38M -5.8%
Net Income-48.09M
EPS-0.06
Shares Out816.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,465,400
Average Volume7,473,130
Open5.88
Previous Close5.93
Day's Range5.72 - 6.01
52-Week Range5.29 - 8.63
Beta-0.12
RSI45.09
Earnings DateApr 25, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay An... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,179
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements